It's a problem for people who work overnights, rotating and early morning shifts.
Kim's work-at-night, sleep-during-the-day schedule has thrown off his hormones and body clock.
"It is not a natural phenomenon for someone to go completely against the grain and kind of fly in the face of mother nature if you will," Dr. Lacey says.
So, when Joe needs to sleep, he can't.
"The end result is that you have cumulative and significant sleep debt and sleep deprivation," Dr. Lacey says. "And, sleep deprivation can cause some very serious medical problems."
Going without sufficient sleep can cause concentration problems, fatigue, depression, and it raises your risk of high blood pressure, diabetes, and other chronic illnesses. To try to head that off, Joe Kim has volunteered for a study at NeuroTrials to test an experimental new drug for people with shift work sleep disorder.Dr. Lacey says the test medication is a non-amphetamine, designed to stimulate wake-promoting transmitters in the brain to help shift workers stay alert on the job
You would take it as-needed, he says, and it's designed to stay in your system for only about 6 or 7 hours.
"So that the person, when they get off their shift can now fall asleep without the difficulties because of the medication no longer in their system."
NeuroTrials research participant Joe Kim & medical director Dr. Michael Lacey were recently featured in a Fox5 piece on shift work sleep disorder.
For more information on this study, visit our study page.
"For many people, one medication does not fit all."
NeuroTrials Research CEO Dr. Russell Rosenberg recently sat down with Keisha Lancelin of Focus Atlanta to discuss treatment-resistant depression & our latest research study for major depressive disorder. Watch the full interview below.
For more information about this study, visit our study landing page.
September 21 is World Alzheimer's Day. Here at NeuroTrials Research, we continue to do our part to further research & seek out cures for Alzheimer's as well as end side effects associated with certain Alzheimer's medication. We are so thankful to our research participants, past and present, who have furthered the medical community's understanding of Alzheimer's disease.
To read about past participants & studies, view our previous media coverage including an AJC article & WSB interview.
For more information on current Alzheimer's studies, visit our studies page.
Are you keeping your brain healthy? 5 simple tips from ADI:
Gunther Eichler, 73, can't fall asleep at night and fights to stay awake during the day.
"I can be sitting here talking to you, and my eyes will close and I can fall asleep," Eichler told 11Alive's Jennifer Leslie.
The Alpharetta resident was diagnosed with Parkinson's disease 14 years ago but just recently began struggling with sleep.
NeuroTrials Research is the only facility in Georgia and only one of 15 nationwide investigating the link between Parkinson’s disease and excessive sleepiness.
Dr. Lacey & Mr. Eichler sat down with Jennifer Leslie at 11Alive to share their stories & information on our latest Parkinson's research.
Read the full article.
More information about the study.
If you’ll be hitting roadways this weekend, NeuroTrials wants to make sure you get enough sleep. As our own Dr. Rosenberg explained to the AJC in an article earlier this year, drowsy driving is comparable to driving drunk. While drunk and distracted driving, like texting, get lots of attention, a sleep deficit can be just as dangerous and it’s something we can easily control, Dr. Rosenberg says. Wishing our family and friends good sleep and safe driving this holiday!
April 23-29, 2017 is the National Sleep Foundation's annual Sleep Awareness Week!
This year, the NSF is exploring the theme “Sleep Better. Feel Better” to inspire Americans to consider how sleep effects their daily lives, and reinforce the many benefits associated with making healthy sleep habits a priority. A good night’s sleep improves not just health, but mood, productivity, well-being, and overall quality of life.
At the end of the week, the NSF will release results from its annual survey of Americans about their overall sleep quality. One figure we already know is that 25% of all Americans have trouble sleeping. If you are among that 25%, you may qualify for a new research study here at NeuroTrials.
Learn more at the study landing page.
“Instead of focusing on the cure, in this unique proof of concept study, we’re trying to better patient’s lifestyle. They can stay on their current medication if they’re stable and that’s a very comforting situation for them.”
Gunther Eichler, 73, from Alpharetta, similarly experiences excessive sleepiness during the day. He’s been living with Parkinson’s since 2003 when shaking in his left hand was the first indication of the disease’s onset. In fact, before he was diagnosed with the disease, he once fell asleep at the wheel and “it almost killed me,” he said.
“I hit a road sign which made such a loud noise that it woke me up. I was headed straight for a bridge and I woke me up just in time,” Eichler, a veteran, said. He no longer drives.
To read the full press release, including interviews with another PD patient, click here.
Have your sleep habits changed with your Parkinson's disease?
You may qualify for this study if you:
For more information call 404-851-9934 or visit the study page.
“I did the study initially just looking for a good night sleep. Doing the studies at NeuroTrials is totally for research. Once the drug (used during the study) is totally approved, it is feasible that you could ask a doctor to prescribe it,” said Debi Kimsey, a retired Atlanta resident who suffers from insomnia and found the research studies online and applied. “The reality is that the compensation for being a participant is good, and there is some satisfaction in knowing that you are working to help others find rest. The facility is top notch and the staff is awesome,” said Kimsey.
In addition to sleep disorders, NeuroTrials works with volunteers to study new medications effects on disorders like Parkinson's, Alzheimer's disease, migraines, and many more. View currently enrolling studies.
Read the full article from the Northside Neighbor.
If you are 55 or older with trouble sleeping, learn more about an insomnia study.
If you are 55 or older & a good sleeper, you may qualify for a healthy sleeper study.
If your sleep habits have changed since being diagnosed with Parkinson’s disease, you may qualify for a new research study examining a study drug for patients with Parkinson's disease experiencing excessive sleepiness. Qualified participants receive compensation for time & travel.
You may qualify if you: